Sep 30, 2018

Neurocrine Biosciences Q3 2018 Earnings Report

Total Revenue
$152M
Previous year: $60.8M
+149.7%
EPS
$0.52
Previous year: -$0.13
-500.0%
Gross Profit
$150M
Previous year: $60.3M
+148.9%
Cash and Equivalents
$196M
Previous year: $268M
-26.9%
Free Cash Flow
$56.6M
Previous year: -$12.1M
-566.9%
Total Assets
$934M
Previous year: $772M
+20.9%

Neurocrine Biosciences

Neurocrine Biosciences